A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
NCT01743729
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
720
Enrollment
INDUSTRY
Sponsor class
Conditions
Dry Eye Disease
Interventions
DRUG:
Lifitegrast
DRUG:
Placebo
Sponsor
Shire